CIK 0001962011 · <br>Emerging growth company
Kairos Pharma, LTD.
Sign in to watch- Ticker
- KAPA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 462993314
- Phone
- 818-404-5541
- Business address
- 2355 WESTWOOD BLVD. #139, LOS ANGELES, CA, 90064
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- CERT Other Certification
- 8-A12B Other Registration of Securities
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- S-1/A Offering Registration Statement
- S-1/A Offering Registration Statement
- S-1/A Offering Registration Statement
- S-1/A Offering Registration Statement
- S-1/A Offering Registration Statement
- S-1 Offering Registration Statement
- DRS/A Other Draft Registration Statement
- DRSLTR Other Correspondence Related to Draft Registration Statement
- UPLOAD Other SEC-generated Letter
- DRSLTR Other Correspondence Related to Draft Registration Statement
Page 6 of 7 · 125 filings